These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 9659069)
1. Thromboembolic complications and pharmacological prophylaxis in orthopaedic surgery. Montebugnoli M; Bugamelli S; Bonfatti M; Facchini F; Pignotti E; Cenacchi A Anaesthesia; 1998 May; 53 Suppl 2():55-6. PubMed ID: 9659069 [TBL] [Abstract][Full Text] [Related]
2. [Assessment of complications of major orthopedic surgery: comparison of indobufen, calcium heparin, and low molecular heparin]. Borghi B; Bassi A; Grazia M; Feoli MA; Pignotti E Minerva Anestesiol; 1996 Mar; 62(3):93-100. PubMed ID: 8767154 [TBL] [Abstract][Full Text] [Related]
3. [Indobufen and calcium heparin for the prevention of thromboembolism in hip prosthesis surgery in patients who have undergone hemodilution]. Borghi B; Bugamelli S; deSimone N; Montebugnoli M; Ferrari S Minerva Anestesiol; 1990 Oct; 56(10):1117-20. PubMed ID: 2290518 [No Abstract] [Full Text] [Related]
4. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment. Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497 [TBL] [Abstract][Full Text] [Related]
5. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group. Kakkar VV; Howes J; Sharma V; Kadziola Z Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310 [TBL] [Abstract][Full Text] [Related]
6. Anaesthesia and autologous transfusion. Borghi B; Bassi A; Grazia M; Gargioni G; Pignotti E Int J Artif Organs; 1995 Mar; 18(3):159-66. PubMed ID: 7499019 [TBL] [Abstract][Full Text] [Related]
8. Thromboembolic disease in hip replacement surgery. Salvati E; Gonzales Della Valle A; Zoppi A; Pavone V Chir Organi Mov; 2005; 90(3):209-28. PubMed ID: 16681100 [TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307 [TBL] [Abstract][Full Text] [Related]
11. [Indications and clinical application of thrombosis prophylaxis. I]. Mittelkötter U; Reith HB; Thiede A Zentralbl Chir; 2000; 125(7):W49-52. PubMed ID: 10960979 [No Abstract] [Full Text] [Related]
12. Dabigatran: new drug. Continue to use heparin, a better-known option. Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411 [TBL] [Abstract][Full Text] [Related]
13. [Evidence-based guidelines for prevention and therapy of venous thromboembolism]. Falciani M; Dilaghi B; Conti AA; Caciolli S; Gensini GF Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):27-35. PubMed ID: 11253337 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study. Yhim HY; Lee J; Lee JY; Lee JO; Bang SM PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415 [TBL] [Abstract][Full Text] [Related]
15. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement. Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569 [TBL] [Abstract][Full Text] [Related]